<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02580968</url>
  </required_header>
  <id_info>
    <org_study_id>643857003534</org_study_id>
    <nct_id>NCT02580968</nct_id>
  </id_info>
  <brief_title>Study of Key Electro-acupuncture Technique on Migraine</brief_title>
  <official_title>Study of Key Electro-acupuncture Technique on Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A random controlled trail to evaluate the efficacy of migraine standard electroacupuncture
      formula, and to analysis the regulation of the intensity-effects and to observe the
      peripheral NO, CGRP and NF-кB expression level of migraine patients after electroacupuncture
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      acupuncture group(group A): treated by acupuncture for 20 days, 1 time per day control
      group(group B): treated by FlunarizineHydrochloride for 20 days, 1 table per day.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Migraine Disability Assessment Questionnaire (MIDAS)</measure>
    <time_frame>20 days</time_frame>
    <description>a scientifically reliable and valid measure of migraine disability that can improve communication between patients and physicians, assess migraine severity and act as an outcome measure to monitor treatment efficacy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The medical outcomes study 36-item short-form health survey(SF-36)</measure>
    <time_frame>20 days</time_frame>
    <description>A 36-item short-form (SF-36) was constructed to survey health status in the Medical Outcomes Study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral Nitrogen Monoxide(NO) protein expression</measure>
    <time_frame>20 days</time_frame>
    <description>marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral Calcitonin gene related peptide(CGRP) protein expression</measure>
    <time_frame>20 days</time_frame>
    <description>marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral Nuclear factor-kappa B(NF-кB) protein expression</measure>
    <time_frame>20 days</time_frame>
    <description>marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) to assess pain</measure>
    <time_frame>20 days</time_frame>
    <description>Visual Analogue Scale (VAS) were applied to measure pain in patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>electro-acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100hz, 2min. electro-acupoint: LI4(Large Intestine4) with LV3(Liver3).5times a week. lasting for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>routin medicine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>one tablet of flunarizine hydrochloride tablet per day. lasting for 20days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>electro-acupuncture</intervention_name>
    <description>electro-acupuncture on acupoints according to the traditional syndrome diagnosis.once per day, for 20 days.</description>
    <arm_group_label>electro-acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>flunarizine hydrochloride</intervention_name>
    <description>flunarizine hydrochloride ，10mg/day，for 20 days。</description>
    <arm_group_label>routin medicine</arm_group_label>
    <other_name>flunarizine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  met the diagnostic criteria for migraine; suffering from migraine attacks; migraine
             attacks for more than 5 days per month, and lasts for 3 months; voluntarily join this
             study with informed consents.

        Exclusion Criteria:

          -  other systemic, neurological and psychiatric disorders; headache caused by other
             diseases; not treatment compliance during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>pei jian, master</last_name>
    <role>Study Director</role>
    <affiliation>Longhua Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Longhua Hospital,Shanghai University of Traditional Chinese Medicine</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>October 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2015</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electroacupuncture therapy</keyword>
  <keyword>Migraine</keyword>
  <keyword>Acupuncture Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Flunarizine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

